MedTrace Logo

Ion Prostate Irradiation

NCT01641185 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2017-05-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and feasibility of primary hypofractionated irradiation of the prostate with carbon ions or protons using the raster scan technique.

Conditions

  • Prostatic Neoplasms

Interventions

PROCEDURE

radiation

radiation with protons or carbon ions

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Klaus Herfarth, Prof. Dr. · University Hospital of Heidelberg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01641185 on ClinicalTrials.gov